NO986198L - Veterinµrbruk av et pleuromutilinderivat - Google Patents

Veterinµrbruk av et pleuromutilinderivat

Info

Publication number
NO986198L
NO986198L NO986198A NO986198A NO986198L NO 986198 L NO986198 L NO 986198L NO 986198 A NO986198 A NO 986198A NO 986198 A NO986198 A NO 986198A NO 986198 L NO986198 L NO 986198L
Authority
NO
Norway
Prior art keywords
veterinary use
pleuromutilin derivative
veterinary
mutlin
methylbutyrylamino
Prior art date
Application number
NO986198A
Other languages
English (en)
Other versions
NO326117B1 (no
NO986198D0 (no
Inventor
David George Sidney Burch
Paul Howard Ripley
Erich Zeisl
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614014.0A external-priority patent/GB9614014D0/en
Priority claimed from GBGB9614015.7A external-priority patent/GB9614015D0/en
Priority claimed from GBGB9614012.4A external-priority patent/GB9614012D0/en
Priority claimed from GBGB9614016.5A external-priority patent/GB9614016D0/en
Priority claimed from GBGB9614013.2A external-priority patent/GB9614013D0/en
Priority claimed from GBGB9614019.9A external-priority patent/GB9614019D0/en
Priority claimed from GBGB9614018.1A external-priority patent/GB9614018D0/en
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of NO986198L publication Critical patent/NO986198L/no
Publication of NO986198D0 publication Critical patent/NO986198D0/no
Publication of NO326117B1 publication Critical patent/NO326117B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO986198A 1996-07-04 1998-12-30 Anvendelse av et pleuromutilinderivat innen veterinærmedisin samt fremgangsmåte for fremstilling av et medikament omfattende forbindelsen NO326117B1 (no)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB9614014.0A GB9614014D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614017.3A GB9614017D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614015.7A GB9614015D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614012.4A GB9614012D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614016.5A GB9614016D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614013.2A GB9614013D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614019.9A GB9614019D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614018.1A GB9614018D0 (en) 1996-07-04 1996-07-04 Organic compounds
PCT/EP1997/003518 WO1998001127A1 (en) 1996-07-04 1997-07-03 Veterinary use of a pleuromutilin derivative

Publications (3)

Publication Number Publication Date
NO986198L true NO986198L (no) 1998-12-30
NO986198D0 NO986198D0 (no) 1998-12-30
NO326117B1 NO326117B1 (no) 2008-09-29

Family

ID=27571326

Family Applications (1)

Application Number Title Priority Date Filing Date
NO986198A NO326117B1 (no) 1996-07-04 1998-12-30 Anvendelse av et pleuromutilinderivat innen veterinærmedisin samt fremgangsmåte for fremstilling av et medikament omfattende forbindelsen

Country Status (25)

Country Link
US (1) US6130250A (no)
EP (4) EP0910363B1 (no)
JP (1) JP4165769B2 (no)
CN (1) CN1121216C (no)
AT (2) ATE509625T1 (no)
AU (1) AU718701B2 (no)
BG (1) BG64369B1 (no)
BR (1) BR9710208A (no)
CA (1) CA2256514C (no)
CZ (4) CZ298444B6 (no)
DE (1) DE69740162D1 (no)
DK (2) DK1813272T3 (no)
ES (2) ES2364414T3 (no)
GB (1) GB9614017D0 (no)
HU (1) HU230325B1 (no)
IL (1) IL127299A (no)
NO (1) NO326117B1 (no)
NZ (1) NZ333261A (no)
OA (1) OA10951A (no)
PL (1) PL189204B1 (no)
PT (2) PT910363E (no)
RU (1) RU2197237C2 (no)
SK (4) SK286445B6 (no)
UA (1) UA56173C2 (no)
WO (1) WO1998001127A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
TWI228048B (en) * 1999-12-09 2005-02-21 Novartis Ag New formulation
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
US6682762B2 (en) * 2001-10-09 2004-01-27 Heart-O-Dixie Animal Nutrition, Llc Poultry and livestock feed additive
CO5390081A1 (es) 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
EP1686115A1 (de) * 2005-01-26 2006-08-02 Novartis AG Organische Säureadditionssalze von Valnemulin
DE102006021493B4 (de) * 2006-05-09 2010-04-01 Bruker Daltonik Gmbh Massenspektrometrische Messung mikrobieller Resistenzen
EP2014645A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives and their use as antimicrobials
CN101690717B (zh) * 2009-09-30 2013-03-06 北京大北农动物保健科技有限责任公司 一种兽用沃尼妙林及其盐的预混剂及制备方法
CN102415989A (zh) * 2011-09-30 2012-04-18 上海恒丰强动物药业有限公司 盐酸沃尼妙林溶液剂及其制备方法
CN103520099A (zh) * 2013-10-30 2014-01-22 王玉万 含有效成份为沃尼妙林的长效注射剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130709A (en) * 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
US4247542A (en) * 1978-06-22 1981-01-27 Eli Lilly And Company A-40104 Antibiotics and process for production thereof
DE3405632A1 (de) * 1984-02-17 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
EP0153277B1 (de) * 1984-02-17 1987-08-26 Sandoz Ag Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
AT392272B (de) * 1989-10-03 1991-02-25 Biochemie Gmbh Verfahren zur herstellung eines pleuromutilinderivats und seiner saeureadditionssalze
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
CN1039585C (zh) * 1993-01-01 1998-08-26 生化企业 截短侧耳素衍生物与环糊精的配合物和含有它的药物制剂

Also Published As

Publication number Publication date
EP1810672A1 (en) 2007-07-25
AU718701B2 (en) 2000-04-20
SK2799A3 (en) 1999-09-10
IL127299A (en) 2005-05-17
EP1808171A1 (en) 2007-07-18
ATE503475T1 (de) 2011-04-15
DK0910363T3 (da) 2011-09-05
JP2000514072A (ja) 2000-10-24
PL330726A1 (en) 1999-05-24
DE69740162D1 (de) 2011-05-12
UA56173C2 (uk) 2003-05-15
NO326117B1 (no) 2008-09-29
CZ298385B6 (cs) 2007-09-19
CZ298446B6 (cs) 2007-10-03
AU3692997A (en) 1998-02-02
ATE509625T1 (de) 2011-06-15
PT910363E (pt) 2011-05-31
EP1813272A1 (en) 2007-08-01
IL127299A0 (en) 1999-09-22
OA10951A (en) 2003-02-26
SK285711B6 (sk) 2007-06-07
HUP9903103A2 (hu) 2000-02-28
ES2360813T3 (es) 2011-06-09
CZ298445B6 (cs) 2007-10-03
EP0910363A1 (en) 1999-04-28
ES2364414T3 (es) 2011-09-01
EP0910363B1 (en) 2011-05-18
NZ333261A (en) 2000-09-29
CA2256514C (en) 2006-11-28
CN1223576A (zh) 1999-07-21
SK286445B6 (sk) 2008-10-07
BG64369B1 (bg) 2004-12-30
PT1813272E (pt) 2011-04-29
EP1813272B1 (en) 2011-03-30
CN1121216C (zh) 2003-09-17
CA2256514A1 (en) 1998-01-15
BR9710208A (pt) 1999-08-10
HUP9903103A3 (en) 2000-04-28
GB9614017D0 (en) 1996-09-04
CZ298444B6 (cs) 2007-10-03
JP4165769B2 (ja) 2008-10-15
WO1998001127A1 (en) 1998-01-15
PL189204B1 (pl) 2005-07-29
SK285857B6 (sk) 2007-09-06
DK1813272T3 (da) 2011-07-18
US6130250A (en) 2000-10-10
HU230325B1 (hu) 2016-02-29
SK286431B6 (sk) 2008-10-07
BG103002A (en) 1999-09-30
CZ438198A3 (cs) 1999-03-17
RU2197237C2 (ru) 2003-01-27
NO986198D0 (no) 1998-12-30

Similar Documents

Publication Publication Date Title
ATE240744T1 (de) Verwendung von csf-1-inhibitoren
ATE120644T1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
NO986198D0 (no) Veterinµrbruk av et pleuromutilinderivat
EA200300544A1 (ru) Эффективные противоопухолевые лекарственные средства
RU94044454A (ru) Ингибитор аутоимунных заболеваний
DE69116380T2 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE450535T1 (de) Neues verfahren zur herstellung von pleuromutilinderivaten
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
RU94044489A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования миелопероксидазной активности
DE3850778D1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69007065T2 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
NO902157D0 (no) Butensyrederivater for terapeutisk anvendelse.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
RU2000118976A (ru) Способ повышения продуктивности молодняка свиней
DE60002552D1 (de) Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
RU94044487A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения мужского бесплодия
NO20082302L (no) Anvendelse av et pleuromutilinderivat innen vetrinaermedisin samt fremgangsmate for fremstilling av et medikament omfattende forbindelsen
DK0437645T3 (da) Imidazolylpropylguanidinderivat, fremgangsmåde til fremstilling deraf og lægemidler indeholdende denne forbindelse
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them
ES2149726B1 (es) Nuevos compuestos de paroxetina.
GB2316406A (en) Free radical scavenger molecules
NZ273710A (en) use of ketoconazole or a derivative which is a cortisol synthesis inhibitor in medicaments for treatment of type II diabetes

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: NOVARTIS TIERGESUNDHEIT AG, CH

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO

MK1K Patent expired